| 25th Jul 2016 7:00 am |
RNS |
Faron enters agreement with Abzena for Clevegen |
| 22nd Jun 2016 12:00 pm |
RNS |
Faron to Present at Proactive Investors Forum |
| 14th Jun 2016 7:00 am |
RNS |
Faron Provides Update at R&D Day |
| 13th Jun 2016 7:00 am |
RNS |
Faron Licenses Traumakine Rights to Pharmbio Korea |
| 26th May 2016 10:53 am |
RNS |
Faron Result of Annual General Meeting |
| 26th May 2016 7:00 am |
RNS |
Faron Expands R&D Strategy for Clevegen |
| 13th May 2016 7:00 am |
RNS |
Faron Pharmaceuticals Ltd to host an R&D Day |
| 4th May 2016 7:00 am |
RNS |
Notice of AGM |
| 3rd May 2016 7:00 am |
RNS |
Faron Appoints New Medical Director |
| 22nd Apr 2016 7:00 am |
RNS |
Faron Appoints Panmure Gordon as Joint Broker |
| 19th Apr 2016 7:00 am |
RNS |
Faron Files Two New Patents to Protect Clevegen |
| 10th Mar 2016 7:00 am |
RNS |
Annual Results for the year ended 31 December 2015 |
| 1st Mar 2016 7:00 am |
RNS |
Faron files patent application for Traumakine |
| 10th Feb 2016 7:00 am |
RNS |
Notice of Preliminary Results |
| 7th Jan 2016 7:00 am |
RNS |
Top-line results from Japanese study of Traumakine |
| 29th Dec 2015 7:00 am |
RNS |
First Patient recruited in Phase III ARDS Study |
| 21st Dec 2015 7:00 am |
RNS |
Faron Awarded ?1.5 million Tekes Funding |
| 30th Nov 2015 7:00 am |
RNS |
Key Publication in Journal of Immunology |
| 17th Nov 2015 7:30 am |
RNS |
Admission to AIM and first day of dealings |
